Identity
- Security key
- 23037
- Ticker
- UNCY
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-07-13
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- UNCY
Detail
Enriched 2026-08-14 20:47
- Market cap
- $150,139,835.23
- Shares outstanding (class)
- 27,393,027
- Shares outstanding (weighted)
- 27,855,257
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 22
- Location
- MOUNTAIN VIEW, CA
- Homepage
- https://www.unicycive.com
- Description
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.